Cargando…
Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report
Gastro-esophageal reflux (GER) is a common and serious complication in patients receiving enteral nutrition, making continuation of enteral nutrition difficult. Semi-solid enteral nutrients were developed to prevent feeding-related GER. Semi-solid enteral nutrients have high viscosity and, therefore...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Clinical Nutrition
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665752/ https://www.ncbi.nlm.nih.gov/pubmed/29124051 http://dx.doi.org/10.7762/cnr.2017.6.4.306 |
_version_ | 1783275191752720384 |
---|---|
author | Akashi, Tetsuro Matsumoto, Kazuhide Hashimoto, Risa |
author_facet | Akashi, Tetsuro Matsumoto, Kazuhide Hashimoto, Risa |
author_sort | Akashi, Tetsuro |
collection | PubMed |
description | Gastro-esophageal reflux (GER) is a common and serious complication in patients receiving enteral nutrition, making continuation of enteral nutrition difficult. Semi-solid enteral nutrients were developed to prevent feeding-related GER. Semi-solid enteral nutrients have high viscosity and, therefore, are typically administered through a large-diameter percutaneous endoscopic gastrostomy (PEG) tube. Recently, a new formula (Mermed(®), Mermed Plus(®)) was introduced that uses alginate, which behaves like a gelatin in acidic conditions. This formula improved GER during enteral feedings. Our case report shows that this new formula enables the continuation of enteral nutrition via a nasogastric tube (NGT) in patients with difficulty tolerating enteral nutrition secondary to vomiting. An 86-year-old woman with an atherothrombotic cerebral infarction vomited during tube feeding, resulting in aspiration pneumonia. After 1 week, we introduced a viscosity regulator and restarted enteral feeding using a 100 mL liquid diet, but vomiting persisted. Because of the continued difficulty in tolerating enteral nutrition, the patient was transferred to our hospital. From hospital day 4, Mermed Plus(®) (300 mL/225 kcal, administered for 1 hour, 3 times a day) was started, eventually increasing to 535 mL/400 kcal at hospital day 5. After this, vomiting ceased. Mermed Plus(®) was easily administered via NGT, and its effects were immediate. This treatment appeared to improve the patient's quality of life while reducing the burden on medical staff. |
format | Online Article Text |
id | pubmed-5665752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean Society of Clinical Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-56657522017-11-09 Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report Akashi, Tetsuro Matsumoto, Kazuhide Hashimoto, Risa Clin Nutr Res Case Report Gastro-esophageal reflux (GER) is a common and serious complication in patients receiving enteral nutrition, making continuation of enteral nutrition difficult. Semi-solid enteral nutrients were developed to prevent feeding-related GER. Semi-solid enteral nutrients have high viscosity and, therefore, are typically administered through a large-diameter percutaneous endoscopic gastrostomy (PEG) tube. Recently, a new formula (Mermed(®), Mermed Plus(®)) was introduced that uses alginate, which behaves like a gelatin in acidic conditions. This formula improved GER during enteral feedings. Our case report shows that this new formula enables the continuation of enteral nutrition via a nasogastric tube (NGT) in patients with difficulty tolerating enteral nutrition secondary to vomiting. An 86-year-old woman with an atherothrombotic cerebral infarction vomited during tube feeding, resulting in aspiration pneumonia. After 1 week, we introduced a viscosity regulator and restarted enteral feeding using a 100 mL liquid diet, but vomiting persisted. Because of the continued difficulty in tolerating enteral nutrition, the patient was transferred to our hospital. From hospital day 4, Mermed Plus(®) (300 mL/225 kcal, administered for 1 hour, 3 times a day) was started, eventually increasing to 535 mL/400 kcal at hospital day 5. After this, vomiting ceased. Mermed Plus(®) was easily administered via NGT, and its effects were immediate. This treatment appeared to improve the patient's quality of life while reducing the burden on medical staff. Korean Society of Clinical Nutrition 2017-10 2017-10-16 /pmc/articles/PMC5665752/ /pubmed/29124051 http://dx.doi.org/10.7762/cnr.2017.6.4.306 Text en Copyright © 2017. The Korean Society of Clinical Nutrition https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Akashi, Tetsuro Matsumoto, Kazuhide Hashimoto, Risa Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title | Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title_full | Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title_fullStr | Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title_full_unstemmed | Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title_short | Continuation of Enteral Nutrition and Relief from Vomiting by Administration of a New Formula: a Case Report |
title_sort | continuation of enteral nutrition and relief from vomiting by administration of a new formula: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665752/ https://www.ncbi.nlm.nih.gov/pubmed/29124051 http://dx.doi.org/10.7762/cnr.2017.6.4.306 |
work_keys_str_mv | AT akashitetsuro continuationofenteralnutritionandrelieffromvomitingbyadministrationofanewformulaacasereport AT matsumotokazuhide continuationofenteralnutritionandrelieffromvomitingbyadministrationofanewformulaacasereport AT hashimotorisa continuationofenteralnutritionandrelieffromvomitingbyadministrationofanewformulaacasereport |